Commit fb724488 authored by 芮自成's avatar 芮自成

专病修改

parent a3f5d86b
......@@ -66,7 +66,7 @@ export default {
if (!token) {
token = sessionStorage.getItem('token')
if (process.env.NODE_ENV !== 'production') {
token = 'e9fa9a17-f2ee-4746-94b5-28ddb5e3d3a3'
token = '919dba4c-4fdc-40ee-805d-ed00d4fc886a'
}
}
if (token) {
......
......@@ -5,7 +5,7 @@
v-model="form.diseaseTypeName"
isLink
readonly
:disabled="$route.query.id"
:disabled="$route.query.id ? true : false"
placeholder="请选择"
:rules="rules.diseaseTypeName"
@click="showDiseaseType = true"
......
......@@ -636,71 +636,6 @@
</van-field>
</div>
<!-- <div class="bg-fa mt-2">
<div class="label-title" required style="color: #262626; font-size: 14px; line-height: 24px">请您确认患者目前服用的降压药、降脂或抗血小板药,在下表中修改或增加,并记录上次随访以来服用的降压药物的依从性</div>
<div style="background-color: #FFF; padding: 8px; border-radius: 10px">
<van-field
label="药物名称"
v-model="form.drinkOther"
placeholder="0~3000,整数"
class="form-input"
label-width="72px"
label-class="label-mr"
>
</van-field>
<van-field
label="剂量"
v-model="form.drinkOther"
placeholder="0~3000,整数"
class="form-input mt-2"
label-width="36px"
label-class="label-mr"
>
</van-field>
<van-field
label="频次"
v-model="form.drinkOther"
placeholder="0~3000,整数"
class="form-input mt-2"
label-width="36px"
label-class="label-mr"
>
</van-field>
<van-field
label="用法"
v-model="form.drinkOther"
placeholder="0~3000,整数"
class="form-input mt-2"
label-width="36px"
label-class="label-mr"
>
</van-field>
<van-field
label="服药依从性"
v-model="form.drinkOther"
placeholder="0~3000,整数"
class="form-input mt-2"
label-width="84px"
label-class="label-mr"
>
</van-field>
<van-field
label="不依从原因"
v-model="form.drinkOther"
placeholder="0~3000,整数"
class="form-input mt-2"
label-width="84px"
label-class="label-mr"
>
</van-field>
</div>
</div> -->
<!-- 药物不良反应 -->
<div class="label-title mt-2" required>药物不良反应</div>
<van-field :rules="rules.drugsAdverse" style="padding: 0">
......
Markdown is supported
0% or
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment